Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49
Last updated 2014-12-05
Summary
The purpose of the study is to evaluate the Calcium homeostasis in adult patients with uncontrolled acromegaly. The measurements will be repeated 3-6 months after the treatment of acromegaly (surgical or medical). The control group consists of patients with nonfunctioning pituitary tumors who will undergo surgical removal.
Conditions
- Acromegaly
- Nonfunctioning Pituitary Tumor
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Adriana Ioachimescu, MD, PhD · Asst Professor
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- United States
Study Locations
More Related Trials
-
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
NCT03807076 ·Status: COMPLETED ·Phase: NA
-
Diet in the Management of Acromegaly
NCT05401084 ·Status: RECRUITING ·Phase: NA
-
Treatment Patterns and Treatment Outcomes for Acromegaly
NCT03043586 ·Status: COMPLETED
-
The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133 ·Status: UNKNOWN
-
Brain-gut Interaction in Irradiated Patients With Acromegaly
NCT02005978 ·Status: UNKNOWN
-
Reproducibility and Utility of OGTT in Acromegaly
NCT04066569 ·Status: COMPLETED ·Phase: NA
-
Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands
NCT06607666 ·Status: COMPLETED
-
Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
NCT02152124 ·Status: COMPLETED
-
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
NCT00225979 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
NCT01295060 ·Status: TERMINATED ·Phase: PHASE3
-
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
NCT06344650 ·Status: RECRUITING
-
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
NCT00647179 ·Status: COMPLETED
-
Open Label Study of Octreotide Implant in Patients With Acromegaly
NCT00913055 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study on Changes in Acromegaly
NCT01612624 ·Status: UNKNOWN
-
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
NCT00376064 ·Status: COMPLETED ·Phase: PHASE4
-
Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
NCT00663000 ·Status: COMPLETED
-
A Prospective Study of Outcome After Therapy for Acromegaly
NCT01809808 ·Status: COMPLETED
-
Evaluation of Somatostatin Receptors and GH Receptor Expression on Bone of Acromegalic Patients (ACRO-BONE)
NCT05819554 ·Status: COMPLETED
-
Effects of Pasireotide Lar Therapy on Bone Metabolism
NCT07179926 ·Status: RECRUITING
-
Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs
NCT01371045 ·Status: WITHDRAWN
-
KETOgenic Diet Therapy in Patients With ACROmegaly
NCT06949891 ·Status: RECRUITING ·Phase: NA
-
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308 ·Status: TERMINATED
-
Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
NCT02012127 ·Status: COMPLETED
-
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
NCT01302652 ·Status: COMPLETED
-
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
NCT00005100 ·Status: UNKNOWN